FDA 483 - Caribe Holdings (Cayman) Co. Ltd dba PuraCap Caribe - July 02, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Caribe Holdings (Cayman) Co. Ltd dba Puracap Caribe in Dorado, PR, revealed significant deficiencies across multiple quality systems. The firm's stability program was found to be inadequate and not followed, with issues in container-closure testing and stability study execution. Additionally, the inspection identified problems with laboratory controls, facility maintenance, equipment cleaning, and the handling of rejected materials, indicating a broad lack of adherence to established procedures and good manufacturing practices.
- Inspection Date
- July 2, 2021
- Product Type
- Drugs
ID · 9635f089-884c-49c7-a3fc-3298b13df5dd